Team:Imperial College London/M2/Genetic

From 2009.igem.org

(Difference between revisions)
(Elaboration)
(Elaboration)
Line 14: Line 14:
==Elaboration==
==Elaboration==
-
This genetic circuit consists of two parts. The first part deals with the production of colanic acid, while the second part deals with the production of trehalose. Colanic acid is being used to encapsulate our drug protein, protecting it from the harsh acidic environment of our gut. Trehalose will ensure the stability of the colanic acid coat.
+
This genetic circuit consists of two parts. The first part deals with the production of colanic acid, while the second part deals with the production of trehalose. Colanic acid is used to encapsulate the drug protein, protecting it from the harsh acidic environment of our gut. Trehalose will preserve the protein structure.
-
Genes RcsB, YgiV and Rfal control the production of colanic acid. RcsB is concerned with the production of colanic acid, YgiV increases the production of colanic acid and Rfal ligates colanic acid produced, to the outer membrane of E. coli.
+
Genes RcsB, YgiV and Rfal control the production of colanic acid. RcsB is concerned with generating colanic acid, YgiV increases the yield and Rfal attaches the colanic acid produced, to the outer membrane of E. coli.
Line 23: Line 23:
-
Encapsulation is auto-induced when the concentration of glucose decreases below threshold. Initially, glucose concentration is high and this represses the CRP promoter. No transcription occurs and encapsulation does not occur. As E. coli grows, it consumes glucose, resulting in a decrease in glucose concentration until the threshold is reached. At this point, glucose will no longer be able to repress the CRP promoter. Colanic acid and trehalose would be produced.
+
Encapsulation is induced automatically when the concentration of glucose decreases below threshold. Initially, glucose concentration is high and this represses the CRP promoter. No transcription occurs and encapsulation does not occur. As E. coli grows, it consumes glucose, resulting in a decrease in glucose concentration until the threshold is reached. At this point, glucose will no longer be able to repress the CRP promoter. Colanic acid and trehalose would be produced.
{{Imperial/09/TemplateBottom}}
{{Imperial/09/TemplateBottom}}

Revision as of 13:40, 11 September 2009

Contents

M2 Genetic Circuit

Video

Genetic circuit

M2.fgc1.jpg M2.fgc2.JPG

Elaboration

This genetic circuit consists of two parts. The first part deals with the production of colanic acid, while the second part deals with the production of trehalose. Colanic acid is used to encapsulate the drug protein, protecting it from the harsh acidic environment of our gut. Trehalose will preserve the protein structure.


Genes RcsB, YgiV and Rfal control the production of colanic acid. RcsB is concerned with generating colanic acid, YgiV increases the yield and Rfal attaches the colanic acid produced, to the outer membrane of E. coli.


Genes OtsA and OtsB are involved in the production of trehalose.


Encapsulation is induced automatically when the concentration of glucose decreases below threshold. Initially, glucose concentration is high and this represses the CRP promoter. No transcription occurs and encapsulation does not occur. As E. coli grows, it consumes glucose, resulting in a decrease in glucose concentration until the threshold is reached. At this point, glucose will no longer be able to repress the CRP promoter. Colanic acid and trehalose would be produced.


Mr. Gene   Geneart   Clontech   Giant Microbes